CAS 3547-07-7
:4-(p-Chlorophenoxy)butyric Acid
Description:
4-(p-Chlorophenoxy)butyric acid, with the CAS number 3547-07-7, is an organic compound characterized by its structure, which includes a butyric acid moiety linked to a p-chlorophenoxy group. This compound typically appears as a white to off-white solid and is soluble in organic solvents, with limited solubility in water. It is known for its role as a plant growth regulator, particularly in agricultural applications, where it can influence plant growth and development by modulating hormonal pathways. The presence of the p-chlorophenoxy group enhances its biological activity, making it effective in promoting root formation and improving crop yields. Additionally, this compound may exhibit varying degrees of toxicity depending on concentration and exposure, necessitating careful handling and application. Its chemical properties, such as melting point, boiling point, and reactivity, are influenced by the functional groups present, which can also affect its environmental persistence and degradation pathways. Overall, 4-(p-Chlorophenoxy)butyric acid is significant in both chemical research and practical applications in agriculture.
Formula:C10H10ClO3
InChI:InChI=1/C10H11ClO3/c11-8-3-5-9(6-4-8)14-7-1-2-10(12)13/h3-6H,1-2,7H2,(H,12,13)/p-1
SMILES:C(CC(=O)[O-])COc1ccc(cc1)Cl
Synonyms:- 4-Cpb
- 4-(4-Chlorophenoxy) butyric acid
- 4-(4-Chlorophenoxy)butanoic acid
- Butanoic acid, 4-(4-chlorophenoxy)-
- 4-(4-Chlorophenoxy)Butanoate
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
4-(P-CHLOROPHENOXY)BUTYRIC ACID
CAS:Formula:C10H11ClO3Purity:98%Color and Shape:SolidMolecular weight:214.64554-(4-Chlorophenoxy)Butanoic Acid
CAS:4-(4-Chlorophenoxy)Butanoic AcidPurity:97%Molecular weight:214.65g/mol4-(4-Chlorophenoxy)butyric acid
CAS:Controlled Product<p>4-(4-Chlorophenoxy)butyric acid (4CBA) is a nitrobenzodiazepine derivative. It has been shown to bind to the benzodiazepine receptor at the same site as benzodiazepines, but with a different conformation. This drug has been shown to be an effective treatment for anxiety, but not depression. In addition, 4CBA has been shown to interact with GABA receptors and modulate their activity. It also appears that this drug may be useful in the treatment of epilepsy and other neurological disorders because it can enhance GABAergic transmission. 4CBA binds to the carboxylate site on GABA A receptors and inhibits chloride ion influx, which leads to membrane hyperpolarization. This binding also causes conformational changes in the receptor protein that have an effect on the binding of other ligands at the same site. The molecular modelling techniques used for this research showed that 4CBA binds in a similar manner as benzod</p>Formula:C10H11ClO3Purity:Min. 95%Molecular weight:214.65 g/mol



